MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
4,396
Beneficiaries
—
Total drug cost
$1.5M
Distinct drugs
54
Brand share
36.6%
Top prescribed drugs
Levetiracetam317 claims
Lamotrigine294 claims
Carbidopa/Levodopa244 claims
Donepezil Hcl242 claims
Memantine Hcl214 claims
QUALITY · MIPS · 2024
Final MIPS score
81.1
Quality
62.1
Cost
74.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.26%
Group
CROSS-REFERENCE